Clinical Trial: The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional




Official Title: The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease, a Placebo Controlled Randomized Clinical Trial

Brief Summary: This randomized clinical trial is designed to evaluate the effect of selected antioxidant vitamins and minerals supplement B-Carotene (6 mg) + Vit.C (200 mg) + Vit.E (200 mg) + Vit. Nicotinamide (20 mg) + Selenium (200 mic.)+ Zinc oxide (8 mg) + Copper oxide (1mg) +Mangeneschloride (1.8 mg) in patients with mild Graves' orbitopathy according to EUGOGO classification.